There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Nanotechnology is an important area of drug and biomedical research, and advancing nano-analysis is crucial for its further development.

Exploring the Tools in Nanoparticle Analysis

Lynn D. Torbeck is an international consultant and trainer specializing in applied statistics and experimental design for pharmaceutical, biopharmaceutical, and medical device research and development, validation, quality control/assurance, and production, 2000 Dempster Plaza, Evanston, IL 60202, tel. 847.424.1314.

A history of the selection of the widely used significance level leaves much to be desired.

Statistical Solutions: On the Verge of Significance: Why 5%

The authors discuss the statistical tools used in experimental planning and strategy and how to evaluate the resulting design space and its graphical representation.

Statistical Considerations in Design Space Development (Part I of III)

Michelle Hoffman, editorial director of Pharmaceutical Technology.

After a spate of industrial disasters, the public seeks greater oversight of corporations-so does FDA.

A Word to the Unwise

Pfizer Suspends Tanezumab Program; Actavis Appoints CEO; And More.

Week of June 28, 2010: Company and People Notes: Pfizer Suspends Tanezumab Program; Actavis Appoints CEO; And More.

Counterfeit pharmaceuticals are complex products that can vary from their legitimate counterparts both chemically and physically.

Near-infrared chemical imaging could hold key data in fight against counterfeiters

Company and People Notes: Valeant and Biovail to Merge; GPhA Names Interim Director; And More.

Week of June 21, 2010: Company and People Notes: Valeant and Biovail to Merge; GPhA Names Interim Director; And More.

GSK Acquires Laboratorios Phoenix; Catalent Makes Executive Appointments; And More.

Week of June 14, 2010: Company and People Notes: GSK Acquires Laboratorios Phoenix; Catalent Makes Executive Appointments; And More.

Thermo Fisher to Acquire Fermentas; Pfizer Names Head of R&D; And More.

Week of May 31, 2010: Company and People Notes: Thermo Fisher to Acquire Fermentas; Pfizer Names Head of R&D; And More.

Sanjay Garg, PhD, is an associate professor at the School of Pharmacy, University of Auckland, Auckland, New Zealand, and a member of the Pharmaceutical Technology Editorial Advisory Board.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes